Korea / KHIDI President Talks Domestic Vaccine R&D
KHIDI’s Soonman KWON outlines the public health R&D funding landscape in Korea, plans to increase Korea’s capacity to develop and produce its own vaccines in the wake of the COVID-19…
Korea Health Industry Development Institute (KHIDI) is a government-affiliated institution which performs professional and systematic support to develop domestic health industry and enhance health services.
Since its establishment in 1999, KHIDI has led expansion of healthcare R&D investment and building competitiveness of Korea’s healthcare industry, i.e., health services, pharmaceuticals, medical devices, food and beauty-cosmetic. We are also witnessing rapid growth of global healthcare sector – especially in attracting foreign patients and exporting healthcare service providers along with healthcare systems. This is a valuable outcome we have earned through years of efforts on global advancement and outreach in this sector.Since its establishment in 1999, KHIDI has been playing a major role in the industry development as the nation’s only one organization responsible for fostering health industry. While we have striven to produce more successful research outcomes by means of greater investments in Health Technology (HT) R&D, KHIDI also took the initiative in increasing competitiveness in different areas of health industry, including pharmaceuticals, medical devices, foods, and beauty & cosmetics businesses.
Contact details:
Address: 187 Osongsaengmyeong2(i)-ro, Gangoe-myeon, Cheongwon-gun, Chungcheongbuk-do, 363-951 Korea
Tel: +82-43-713-8000 ~ 8005
KHIDI’s Soonman KWON outlines the public health R&D funding landscape in Korea, plans to increase Korea’s capacity to develop and produce its own vaccines in the wake of the COVID-19…
Brian Gladsden was appointed president of Novartis Korea in January 2014. He relates his previous experience to the market situation in Korea and highlights the importance of commitment to innovation…
The American Chamber of Commerce in Korea (Amcham Korea) was established in 1953 and has a long history in developing bilateral economic and trade relations between the US and Korea. Amy…
Cho Chan-Hwui, president of the Korean Pharmaceutical Association (KPA), discusses the major hurdles that pharmacists in Korea must overcome today, and the increased focus on prescription by INN. How…
Hakim Djaballah arrived to Institut Pasteur Korea in July 2014 with an aim to return to the French institute’s focus on infectious diseases. He outlines the complexities of Korea’s research…
Dr. Jung Yun-Taek, head researcher of the pharmaceutical division at the Korea Health Industry Development Institute (KHIDI), discusses the real potential that Korean pharmaceutical companies offer to the rest of…
The European Chamber of Commerce in Korea (ECCK) was founded in 2012, in order to represent the interests of European businesses in Korea. Christoph Heider, secretary general of ECCK, discusses…
Yuhan is one of the largest and fastest growing pharmaceutical companies in South Korea, with a long history in the sector. In your view, what are the main elements that…
South Korea has a much shorter history of clinical trials than many other advanced economies. In your view, what is the potential for South Korea’s clinical trial industry today? The…
After spending a large part of your career as a university professor, what drove you to create your own company, Histostem, in 2000? In 1993, I actually established a bone…
Could you please introduce KPMA and explain the role it plays within the South Korean pharmaceutical industry? KPMA is the only association in South Korea regrouping the whole range of…
LG Life Sciences seems quite unique among the rest of pharmaceutical companies in Korea which tend to be family owned. How has this set LGLS apart in terms of its…
Could you introduce Lee & Ko to our readers? Established in 1977, Lee & Ko is the largest and the leading law firm in Korea, consisting of 310 professionals, including…
See our Cookie Privacy Policy Here
